ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $1,681,000 | +90.2% | 36,278 | 0.0% | 0.04% | +75.0% |
| Q1 2019 | $884,000 | +71.0% | 36,278 | 0.0% | 0.02% | +53.8% |
| Q4 2018 | $517,000 | -48.7% | 36,278 | -45.3% | 0.01% | -13.3% |
| Q3 2018 | $1,008,000 | +98.4% | 66,356 | +119.2% | 0.02% | +36.4% |
| Q2 2018 | $508,000 | +20.7% | 30,278 | +17.5% | 0.01% | +10.0% |
| Q1 2018 | $421,000 | +77.6% | 25,778 | +39.5% | 0.01% | +233.3% |
| Q4 2017 | $237,000 | – | 18,478 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|